Understanding COVID-19: Minnesota-Cuba Innovations & Research

Understanding COVID-19: Minnesota-Cuba Innovations & Research
jbriquel

On December 16, 2020, leaders in public health, nursing, and medicine from the University of Minnesota and Cuba gathered at a virtual forum to share their experiences working on the frontlines against COVID-19. Panelists explored topics related to: public health measures, clinical care and therapies, and the outlook on new vaccines.

We anticipate holding future events and opportunities that advance discussion and information sharing between Cuba and Minnesota.

Moderator: Gail Reed, Executive Editor of MEDICC Review

Video 1: Welcome Remarks

Brief overview

  • COVID in Minnesota: Michael Osterholm, PhD, Regents Professor of Public Health, Director, Center for Infectious Disease Policy
  • COVID in Cuba: Francisco Durán, MD, National Director of Epidemiology Cuba

Containment: Schools and universities

  • Cuba: Ileana Morales Suarez MD, MS National Director of Science and Technology Innovation for the Ministry of Health
  • Minnesota: Jakub Tolar, Dean of Medical School, Vice President for Clinical Affairs

Clinical trials and vaccines

  • Cuba: Dagmar García, Director of Research Finlay Vaccine Institute
  • Minnesota: Tim Schacker, MD, Clinical Trials for Treatments and Vaccination, VP Medical School

Clinical care during and after COVID

  • Cuba (Acute Care): Daniel González, MD, Director of Clinical Car Tropical Medical Institute
  • Minnesota (Post-Acute Care): Laura Reed, DNP, RN Chief Nursing Executive and Chief Operating Officer, MHealth Fairview, speaking about COVID Survivor Clinic'

Video 2: Closing Remarks